In partnership with

Why Pro Athletes Put Seven Figures Into This Medical Breakthrough

As a third-generation Brazilian Jiu-Jitsu master and former WWE champion, few people understand joint health like Rener and Eve Gracie.

They’ve dedicated their lives to keeping the body in peak shape. So when they made a seven-figure investment into Cytonics, the medical and investment world noticed.

Cytonics developed potentially the first and only treatment that can reverse the effects of osteoarthritis, the world’s most common cause of joint pain. This therapy attacks the root cause of the disease, finally making a solution possible. Big Pharma has chased for years.

With the osteoarthritis treatment market worth $500B, and current treatments only masking pain, it’s easy to see why the Gracies got involved. Now, you can join them as an early-stage Cytonics investor.

Was this email forwarded to you? Sign up here

We are seeing 10x more companies being built. The early reality of AI.

The number of decks, pitches, Linkedin messages we are seeing for new companies being built is at the highest level in years. The AI for X, or we are rolling up the industry with AI native technology. The number of companies all building the same thing is also peaking.

I get an AI dealflow pitch every day. “We help VC and PE investors find new opportunities using AI!” or “Wouldn’t it be great to wake up to 10 new deals every day found by an AI Agent?” The number of people building the same thing or similar things that have been vibe-coded over a weekend is peaking. Is there money to be made? Absolutely. Are they VC-type investable businesses? Probably not, or if they are, only .001% of them are.

I have written this previously and saw it again recently in this newsletter below, but the key to winning right now is distribution/marketing/sales. Building is getting easier. Sales and distribution are what set people apart right now.

I think AI is changing everything, and it’s exciting. I have been building, my partners have been building, and Ethan on our team has made our operations infinitely more efficient. Our research process is completely flipped on its head, and I can’t imagine going back at this point as I sit up at night doing diligence on investment opportunities, talking to ChatGPT to test my ideas, researching industries, and building out memos for our team.

There is slop everywhere. There are so many AI point solutions. Lots of these tools are cool. Lots of these tools are helpful. But lots of these tools see incredible churn. AI is changing so fast, and it’s hard for all of these companies to keep up.

For better or for worse, AI is giving us more more more.

Reply

Avatar

or to participate

Keep Reading